Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05860270
PHASE4

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.

Official title: The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis, a Multicenter Randomized Controlled Trial

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

176

Start Date

2023-06-15

Completion Date

2026-05-31

Last Updated

2024-08-06

Healthy Volunteers

No

Interventions

DRUG

Cholecalciferol

Patients in the intervention group will receive oral cholecalciferol 4000U per day.

DRUG

Placebo

Patients in the control group will receive placebo 2 capsules per day.

Locations (1)

Peking University First Hospital

Beijing, Beijing Municipality, China